SCHEMBL29650131

SCHEMBL29650131

CC(C)(C)OC(=O)N1CCC(CCn2cc(C#N)cn2)CC1.CN1CCC(CCn2cc(CN)cn2)CC1

nearest known ligand 0.49

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 14/20 0.41
▸ P2RX7 Q99572 2/20 0.39
▸ CETP P11597 1/20 0.39
▸ FAAH O00519 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24493286 0.90 GPR119 (0.48) GPR119CETPFAAH
SCHEMBL24493212 0.81 GPR119 (0.48) GPR119FAAH
SCHEMBL24493084 0.78 ACHE (0.40) —
SCHEMBL24493082 0.77 ACHE (0.41) —
SCHEMBL15939449 0.77 GPR119 (0.46) GPR119P2RX7FAAH
SCHEMBL29079551 0.75 GPR119 (0.46) GPR119P2RX7FAAH
SCHEMBL25269372 0.75 P2RX7 (0.47) GPR119P2RX7FAAH
SCHEMBL16012151 0.72 FAAH (0.50) GPR119FAAH
SCHEMBL22719074 0.71 DDB1 (0.53) GPR119
SCHEMBL26229010 0.71 DDB1 (0.53) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4255900-A2 ENZYME INHIBITORS Kalvista Pharmaceuticals Limited (GB) 2023-10-11 — — EP disclosed
WO-2022118016-A2 ENZYME INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2022-06-09 — — WO disclosed
Send feedback